Both NMN and NR have substantial published research bases. The following summarises the current state of the evidence — not health claims, but factual descriptions of published research. View our full research references →
NMN research
NMN's research base has grown rapidly since 2016. A systematic review published in 2023 (Yi et al.) covering 10 randomised controlled trials with 437 participants documented that oral NMN supplementation consistently elevated blood NAD+ levels across doses from 250 to 900mg per day, with a strong safety profile and no significant adverse events. See our NMN dosage guide for full study details.
NR research
NR has a slightly older published research history, with human studies beginning earlier than NMN. Published NR research has documented NAD+ elevation following supplementation across multiple research contexts. NR's research base is established — NMN's has grown faster in recent years and now includes more human trials and a systematic review of RCTs.
Key distinction
NMN now has more published peer-reviewed human studies than NR, including a systematic review of randomised controlled trials — the highest quality level of published evidence. This reflects the rapid growth of NMN research since 2016, not a deficiency in NR research.
Important: The above describes published research about these compounds as substances — not health claims. All Vitality Supplements products are food supplements not intended to diagnose, treat, cure or prevent any disease.